ALERTS, CHARTS, & HOT STOCKS

[BioSpecialist]

RSLS =MC $2 M /O/S 353 K / Cash $7.7M-- this SUPER EXTREME low float is close to profitability . Lap band to treat Obesity is marketed international. This unknown gem is a potential $100 stock trading at laughable $5.50.A MONSTER Opp here guys


ReShape Lifesciences, Inc. is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. Our current portfolio includes the LAP-BAND® Adjustable Gastric Banding System and the ReShape VestTM*, an investigational device, to help treat more patients with obesity.


Reshape Lifescience (RSLS)

Market Cap: $2 M
Cash: $7.7 M
Price $6

Shares Out: 353K << over 200k shares owned by Armistice


Revenue expected to be around $15 million --Product Lap band aquired december 2018 -- lap Band was owned by Allergan at its Peak the product hit almost $300 Million


MASSIVE insider buying
https://www.secform4.com/insider-trading/1371217.htm


presentation
https://ir.reshapelifesciences.com/static-files/b1a15609-3950-47ad-b00f-ef8430fd1a30

•Acquired in December 2018
•Global regulatory approval
•Only obesity device reimbursed in U.S.

•High-margin product, maintained ASP
•Focus commercial organization on strategic markets for LAP-BAND® •Drive revenue utilizing new long-term clinical data and patient marketing
•Achieve revenues and profits to meet criteria for NASDAQ listing